(UroToday.com) During the first testicular cancer session at the 2020 Annual Meeting of the Society of Urologic Oncology, Dr. Clint Cary tackled management of one of the rarest and difficult patient populations in urologic oncology: those with late recurrence or relapse of testicular cancer.